期刊文献+

儿童过敏性鼻炎特异性免疫治疗过程中外周血CD4^+调节性T细胞的变化及意义 被引量:11

The change of CD4^+regulatory T cells in Children with Allergic Rhinitis after immunotherapy
下载PDF
导出
摘要 目的探讨儿童过敏性鼻炎(allergic rhinitis,AR)的发病及特异性免疫治疗(specific immunotherapy,SIT)的治疗机制。方法采用流式细胞术检测56例AR患者SIT治疗前、治疗1年后外周血中CD4+CD25+CD127lo/-Treg表达水平:采用ELISA法检测血清中IL-10、TGF-β1,并与30例健康儿童进行对比。结果 56例AR患儿SIT治疗前外周血中CD4+CD25+CD127lo/-Treg占CD4+T细胞的百分比为(5.36±1.31)%,显著低于对照组(10.23±2.26)%,P<0.05,但SIT治疗1年后其数值为(9.37±2.15)%,与对照组无明显差异。AR患儿治疗前血清中IL-10值为(3.68±1.21)pg/ml,显著低于对照组的(12.37±2.18)pg/ml,P<0.05;TGF-β1表达水平与对照组比较差异无统计学意义。SIT治疗1年后血清中IL-10水平亦与对照组差异不明显(P<0.05);而TGF-β1表达水平分别为(20.16±4.45)pg/ml及(9.27±2.38)pg/ml,其差异有统计学意义(P<0.05)。结论儿童AR患者外周血中CD4+Treg表达水平低,且存在功能缺陷,导致体内诱导免疫耐受机能不足,SIT治疗可以明显调节免疫免疫细胞的功能。 Objective To explore the change of CD4+ regulatory T cells and the changes of NK cells、IL-10、TGF-β1 in children with allergic rhinitis after one year specific immunotherapy treatment. This study is also aimed prelim-inarily to the pathogenesis and treatment of SIT in children with AR. Methods The peripheral blood of 56 AR patients and 30 healthy subjects were used to measure the proportion of CD4+CD25+CD127lo/-T cell population in CD4+T cells by flow cytometry and the IL-10、TGF-β1 levels were measured by enzyme-linked immunoabsorbent assay. After one year of SIT, we assayed all these parameters again. Results The population of CD4+CD25+CD127lo/- T cells in the peripheral blood of AR patients accounted for (5.36 &#177;1.31)% of CD4+ T lymphocytes, which was significantly lower than that in healthy individuals (10.23&#177;2.26)%(P&lt;0.05). After one year of SIT, the population of CD4+CD25+CD127lo/-T cells in pe-ripheral blood of AR patients accounted for (9.37 &#177;2.15)% of CD4 + T lymphocytes, closeto the normal level (10.23&#177;2.26)%(P&gt;0.05). The serum IL-10 before treatment from children with AR was significantly lower than that from healthy children (P&lt; 0.05); no difference was shown in the serum TGF-β1 level before treatment between children with AR and healthy children (P&gt;0.05). After SIT, the serum IL-10 increased and had no difference compared with that from healthy children (P&lt;0.05), whereas serum TGF-β1 was significantly increased and higher than that from healthy children (P&lt;0.05). Conclusion The CD4+regulatory T cells in the peripheral blood of AR patients are significantly decreased and its function is defected, which leads to immune regulatory dysfunction in vivo. SIT can improve the function of immune cells.
出处 《北京医学》 CAS 2014年第4期269-271,共3页 Beijing Medical Journal
基金 温州市科技局基金资助项目(Y20110143)
  • 相关文献

参考文献10

  • 1Zhang L, Han D, Huang D, et al. Prevalence of self-reported al- lergic rhinitis in eleven major cities in china [J]. Int Arch Allergy Immunol, 2009, 149:47-57.
  • 2Kong WJ, Chen JJ, Zheng ZY, et al. Prevalence of allergic rhinitis in 3-6-year-old children in Wuhan of China [J]. Clin Exp Aller- gy, 2009, 39:869-874.
  • 3Robinson DS. Th-2 cytokines in allergic disease [J]. Br Med Bull, 2000, 56:956-968.
  • 4Liu W, Putnam AL, Xuyu Z, et al. CD127 expression inversely correlates with Foxp3 and suppressive function of human CD4 + Treg cells [J]. J Exp Med, 2006, 203:1701-1711.
  • 5Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of in- terleukin IL-2 and IL-7 receptors discriminates between human regulatory and activated T cells [J]. J Exp Med, 2006, 203: 1693-1700.
  • 6Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells [J]. Nat Rev Immunol, 2003, 3:253-257.
  • 7Roncador G, Brown PJ, Maestre L, et al. Analysis of Foxp3 protein expression in human CD4+ CD25+ regulatory T cells at the sin- gle-cell level [J]. Eur J Immunol, 2005, 35:1681-1691.
  • 8章圣辉,韩义香,吴建波,胡晓霞,陈丹.强直性脊柱炎患者外周血CD4^+调节性T细胞的变化及意义[J].中华微生物学和免疫学杂志,2008,28(5):445-449. 被引量:5
  • 9Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immue tolerance [J]. Cell, 2008, 133:775-787.
  • 10娄玮,王成硕,张罗.调节性T细胞在过敏性鼻炎及抗原特异性免疫治疗中的作用[J].首都医科大学学报,2012,33(6):729-734. 被引量:19

二级参考文献15

  • 1Huanfa Yi,Yu Zhen,Lingling Jiang,Jialin Zheng,Yong Zhao.The Phenotypic Characterization of Naturally Occurring Regulatory CD4^+CD25^+T Cells[J].Cellular & Molecular Immunology,2006,3(3):189-195. 被引量:31
  • 2Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4^+ Treg cells. J Exp Med, 2006, 203(7) : 1701-1711.
  • 3Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med, 2006, 203 ( 7 ) : 1693-1700.
  • 4Van der Linden SJ, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum, 1984, 27 (4): 361-368.
  • 5Calin A, Garrett S, Kennedy LG, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol, 1994, 21(12): 2281-2285.
  • 6Roncador G, Brown PJ, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4^+ CD25^+ regulatory T cells at the single-cell level. Eur J Immunol, 2005, 35(6) : 1681-1691.
  • 7Chavez H, Beaudreuil S, Abbed K, et al. Absence of CD4 CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade. Transpl Immunol, 2007, 17(4) : 243-248.
  • 8He JS, Ostergaard HL. CTLs contain and use intracellular stores of FasL distinct from cytolytic granules. J Immunol, 2007, 179 (4) : 2339-2348.
  • 9Wan YY, Flavell RA. Regulatory T cells, transforming growth factor-beta, and immune suppression. Proc Am Thorac Soc, 2007, 4 ( 3 ) : 271-276.
  • 10McLeod C, Bagust A, Boland A, et al. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess, 2007, 11(28): 1-158.

共引文献22

同被引文献111

  • 1刘思强,马丽娜.舌下含服脱敏治疗小儿过敏性鼻炎的效果及对患儿免疫功能的影响[J].湖南师范大学学报(医学版),2019,16(4):30-33. 被引量:10
  • 2钟玉红.氯雷他定治疗过敏性鼻炎的疗效分析[J].中国急救医学,2018,38(A01):252-252. 被引量:13
  • 3徐佩茹,李敏.过敏性鼻炎的诊断与治疗新进展[J].临床儿科杂志,2007,25(1):4-7. 被引量:84
  • 4Cheryl S. Hankin,Linda Cox,David Lang,Amy Bronstone,Paul Fass,Bryan Leatherman,Zhaohui Wang.Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study[J]. Annals of Allergy, Asthma & Immunology . 2010 (1)
  • 5Jung JH,Kang IG,Kim ST.Comparison of component-resolved diagnosis by using allergen microarray with the conventional tests in allergic rhinitis patients:the first using in Korea[J].Clin Exp Otorhinolaryngol,2015,8(4):385-389.
  • 6Kumar R,Gupta N,Kanuga J,et al.A comparative study of skin prick test versus serum-specific ige measurement in indian patients with bronchial asthma and allergic rhinitis[J].Indian J Chest Dis Allied Sci,2015,57(2):81-85.
  • 7Bourret R,Bousquet J,Mercier J,et al.MASK-rhinitis,a single tool for integrated care pathways in allergic rhinitis[J].World Hosp Health Serv,2015,51(3):36-39.
  • 8Janyacharoen T,Kunbootsri N,Arayawichanon P,et al.Responses of six-weeks aquatic exercise on the autonomic nervous system,peak nasal inspiratory flow and lung functions in young adults with allergic rhinitis[J].Iran J Allergy Asthma Immunol,2015,14(3):280-286.
  • 9Nesterova KI,Nesterova AA.The effectiveness of topical antihistamine monotherapy in the patients presenting with the manifestations of seasonal allergic rhinitis[J].Vestn Otorinolaringol,2015,80(4):77-80.
  • 10Blume SW,Yeomans K,Allen-Ramey F,et al.Administration and burden of subcutaneous immunotherapy for allergic rhinitis in U.S.and Canadian clinical practice[J].J Manag Care Spec Pharm,2015,21(11):982-990.

引证文献11

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部